Improving in the fasting, but not the postprandial, glucose level is associated with reduction of plasma d-ROMs level in patients with type 2 diabetes

Journal of Nippon Medical School

Volumn 80, Issue 3, 2013, Pages 200-210

  Ohara, Makoto ^a   Watanabe, Kentaro ^a   Suzuki, Tatsuya ^a   Sekimizu, Ken Ichi ^a   Motoyama, Masayuki ^a   Ishii, Kazuhito ^a   Sawai, Keisuke ^a   Nakano, Hiroshi ^a   Oba, Kenzo ^a   Mizuno, Kyoichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

And postprandial glucose; Daily profile of plasma glucose; Diacron reactive oxygen metabolites; Oxidative stress; Type 2 diabetes

Indexed keywords

DIACRON REACTIVE OXYGEN METABOLITE; INSULIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; EVALUATION; FEMALE; GLUCOSE METABOLISM; HOSPITALIZATION; HUMAN; MALE; MEAN AMPLITUDE OF GLYCEMIC EXCURSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PARAMETERS; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; POSTPRANDIAL PERIOD; REACTIVE OXYGEN SPECIES; REGRESSION ANALYSIS;

EID: 84879032564     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.80.200     Document Type: Article

References (51)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. Evans M: The UK prospective diabetes study. Lancet 1998; 352: 1932-1933.
3. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-1s625.
4. Haberland ME, Fogelman AM: The role of altered lipoproteins in the pathogenesis of atherosclerosis. Am Heart J 1987; 113: 573-577.
5. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
6. Morrow JD, Frei B, Longmire AW, et al.: Increase in circulating products of lipid peroxidation (f2- isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-1203.
7. Robertson RP: Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-42354.
8. Paolisso G, D'Amore A, Volpe C, et al.: Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 1994; 43: 1426-1429.
9. Matsushima S, Kinugawa S, Yokota T, et al.: Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am J Physiol Heart Circ Physiol 2009; 297: H409-H416.
10. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-1616.
11. Mori Y, Itoh Y, Obata T, Tajima N: Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes. Endocrine 2006; 29: 143-148.
12. Chakraborty A, Chowdhury S, Bhattacharyya M: Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Res Clin Pract 2011; 93: 56-62.
13. Bunck MC, Cornàr A, Eliasson B, et al.: One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress. Atherosclerosis 2010; 212: 223-229.
14. Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC: Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes. Eur J Pharmacol 2011; 659: 296-301.
15. Monnier L, Mas E, Ginet C, et al.: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
16. Siegelaar SE, Barwari T, Kulik W, Hoekstra JB, DeVries JH: No relevant relationship between glucose variability and oxidative stress in wellregulated type 2 diabetes patients. J Diabetes Sci Technol 2011; 5: 86-92.
17. Hirose H, Kawabe H, Komiya N, Saito I: Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb 2009; 16: 77-82.
18. Kamezaki F, Yamashita K, Kubara T, et al.: Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb 2008; 15: 206-212.
19. Seino Y, Nanjo K, Tajima N, et al.: The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1: 2-20.
20. Japanese Society of Hypertension Committee: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
21. Naruse R, Takebayashi K, Morita K, Aso Y, Inukai T: Comparison of effects of insulin aspart three times a day versus insulin detemir once a day on oxidative stress in patients with type 2 diabetes. Endocr J 2011; 58: 1055-1063.
22. Magata Y, Oba K, Inuzuka Y, Nakano H: Aging per se does not influence postprandial glucose levels in type 2 diabetes. Geriatr Gerontol Int 2005; 5: 146-151.
23. Monnier L: Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? Eur J Clin Invest 2000; 30 (Suppl 2): 3-11.
24. Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care 2003; 26: 881-885.
25. Kigawa Y, Oba K, Futami-Suda S, et al.: Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients. Geriatr Gerontol Int 2008; 8: 160-165.
26. Cesarone MR, Belcaro G, Carratelli M, et al.: A simple test to monitor oxidative stress. Int Angiol 1999; 18: 127-130.
27. Lindsey ME, Tarr MA: Quantisation of hydroxyl radical during Fenton oxidation following a single addition of iron and peroxide. Chemosphere 2000; 41: 409-417.
28. Kehrer JP: The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000; 149: 43-50.
29. Seino Y, Nanjo K, Tajima N, et al.: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1: 2-20.
30. Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G: Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag 2011; 7: 475-482.
31. Kotani K, Taniguchi N: The association between reactive oxygen metabolites and metabolic syndrome in asymptomatic Japanese men. J Clin Med Res 2011; 3: 247-251.
32. Ceriello A: The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000; 16: 125-132.
33. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
34. Ceriello A, Esposito K, Piconi L, et al.: Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients. Diabetes 2008; 57: 1349-1354.
35. Nakagami T: Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004; 47: 385-394.
36. The DECODE study group on behalf of the European Diabetes Epidemiology Group: Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 1999; 354: 617-621.
37. Mita T, Watada H, Shimizu T, et al.: Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control. Arterioscler Thromb Vasc Biol 2007; 27: 2456-2462.
38. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N: Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 2006; 91: 837-842.
39. Raz I, Wilson PW, Strojek K, et al.: Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 2009; 32: 381-386.
40. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH: Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008; 51: 183-190.
41. Siegelaar SE, Kulik W, van Lenthe H, Mukherjee R, Hoekstra JB, Devries JH: A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress. Diabetes Obes Metab 2009; 11: 709-714.
42. Monnier L, Colette C, Mas E, et al.: Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy. Diabetologia 2010; 53: 562-571.
43. Tanaka A, Azuma K, Toyofuku Y, et al.: Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 2006; 350: 195-201.
44. Arcaro G, Cretti A, Balzano S, et al.: Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105: 576-582.
45. Choi SW, Benzie IF, Lam CS, et al.: Interrelationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus. Diabet Med 2005; 22: 1347-1353.
46. Kostapanos MS, Spyrou AT, Tellis CC, et al.: Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress. Lipids 2011; 46: 341-348.
47. Gianturco V, Bellomo A, D'Ottavio E, et al.: Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr 2009; 49 (Suppl 1): 129-133.
48. Yamaoka-Tojo M, Tojo T, Kosugi R, et al.: Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia. Lipids Health Dis 2009; 8: 41.
49. Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L: The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance. Clin Endocrinol (Oxf) 2008; 68: 716-723.
50. Nagashima T, Oikawa S, Hirayama Y, et al.: Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients. Diabetes Res Clin Pract 2002; 56: 19-25.
51. Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ: Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 2005; 28: 2465-2471.